LncRNA MAGI2-AS3 promotes fracture healing through downregulation of miR-223-3p

  • 0Department of Orthopedics, Xi'an International Medical Center Hospital, Xi'an, 710000, China.

|

|

Summary

This summary is machine-generated.

Long non-coding RNA MAGI2-AS3 (MAGI2-AS3) promotes fracture healing by upregulating osteogenic markers and cell proliferation. MAGI2-AS3 may serve as a biomarker for delayed fracture healing by targeting miR-223-3p.

Area Of Science

  • Molecular Biology
  • Biochemistry
  • Regenerative Medicine

Background

  • Long non-coding RNAs (LncRNAs) play a crucial role in fracture healing and stem cell osteogenic differentiation.
  • The specific role and molecular mechanisms of lncRNA MAGI2-AS3 (MAGI2-AS3) in fracture healing require further investigation.

Purpose Of The Study

  • To investigate the molecular mechanism and regulatory significance of lncRNA MAGI2-AS3 in fracture healing.
  • To evaluate MAGI2-AS3 as a potential biomarker for delayed fracture healing.

Main Methods

  • Serum MAGI2-AS3 levels were quantified using RT-qPCR in patients with normal and delayed fracture healing.
  • MC3T3-E1 cells were used to assess the effects of MAGI2-AS3 on cell viability, apoptosis, and osteogenic marker expression.
  • Dual-luciferase reporter assays confirmed the interaction between MAGI2-AS3 and miR-223-3p.

Main Results

  • Serum MAGI2-AS3 expression was significantly lower in patients with delayed fracture healing.
  • Overexpression of MAGI2-AS3 enhanced MC3T3-E1 cell proliferation, osteogenic marker expression, and reduced apoptosis.
  • MAGI2-AS3 directly targets and regulates miR-223-3p, which mediates the effects of MAGI2-AS3 on osteogenesis and cell apoptosis.

Conclusions

  • Upregulation of MAGI2-AS3 promotes fracture healing by targeting miR-223-3p.
  • MAGI2-AS3 serves as a potential diagnostic biomarker for identifying patients with delayed fracture healing.